Overview

A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a study of blood plasma levels of methylphenidate in healthy volunteers over a 24 hour period after they take this medication.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen-Ortho Inc., Canada
Treatments:
Methylphenidate